Gene-gene interaction between the cystathionine β-synthase 31 base pair variable number of tandem repeats and the methylenetetrahydrofolate reductase 677 C > T polymorphism on homocysteine levels and risk for neural tube defects

Molecular Genetics and Metabolism

Volumn 78, Issue 3, 2003, Pages 211-215

  Afman, Lydia A ^a   Lievers, Karin J A ^a   Kluijtmans, Leo A J ^a   Trijbels, Frans J M ^a   Blom, Henk J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cystathionine synthase; Homocysteine; Methylenetetrahydrofolate; Neural tube defects; Vitamin B6

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE; PYRIDOXINE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BASE PAIRING; CONTROLLED STUDY; DNA SCREENING; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RISK FACTOR; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0037342358     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-7192(03)00021-0     Document Type: Article

References (20)

1. Prevention of neural tube defects:results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group, Lancet 338 (1991) 131-137.
2. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327:1992;1832-1835.
3. Daly L.E., Kirke P.N., Molloy A., Weir D.G., Scott J.M. Folate levels and neural tube defects. Implications for prevention. JAMA. 274:1995;1698-1702.
4. Steegers-Theunissen R.P., Boers G.H., Trijbels F.J., Finkelstein J.D., Blom H.J., Thomas C.M., Borm G.F., Wouters M.G., Eskes T.K. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 43:1994;1475-1480.
5. Mills J.L., McPartlin J.M., Kirke P.N., Lee Y.J., Conley M.R., Weir D.G., Scott J.M. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 345:1995;149-151.
6. van der Put N.M., Thomas C.M., Eskes T.K., Trijbels F.J., Steegers-Theunissen R.P., Mariman E.C., De Graaf-Hess A., Smeitink J.A., Blom H.J. Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM. 90:1997;505-510.
7. Quere I., Paul V., Rouillac C., Janbon C., London J., Demaille J., Kamoun P., Dufier J.L., Abitbol M., Chasse J.F. Spatial and temporal expression of the cystathionine β-synthase gene during early human development. Biochem. Biophys. Res. Commun. 254:1999;127-137.
8. Van der Put N.M., Steegers-Theunissen R.P., Frosst P., Trijbels F.J., Eskes T.K., van den Heuvel L.P., Mariman E.C., den Heyer M., Rozen R., Blom H.J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346:1995;1070-1071.
9. Botto L.D., Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol. 151:2000;862-877.
10. Lievers K.J., Kluijtmans L.A., Heil S.G., Boers G.H., Verhoef P., van Oppenraay-Emmerzaal D., den Heijer M., Trijbels F.J., Blom H.J. A 31. bp VNTR in the cystathionine β-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels Eur. J. Hum. Genet. 9:2001;583-589.
11. Yang F., Hanson N.Q., Schwichtenberg K., Tsai M.Y. Variable number tandem repeat in exon/intron border of the cystathionine β-synthase gene: a single nucleotide substitution in the second repeat prevents multiple alternate splicing. Am. J. Med. Genet. 95:2000;385-390.
12. Den Heijer M., Blom H.J., Gerrits W.B., Rosendaal F.R., Haak H.L., Wijermans P.W., Bos G.M. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet. 345:1995;882-885.
13. Te Poele-Pothoff M., van den Berg M., Franken D.G., Boers G.H., Jakobs C., de K.I., Eskes T.K., Trijbels J.M., Blom H.J. Three different methods for the determination of total homocysteine in plasma. Ann. Clin. Biochem. 32:1995;218-220.
14. ′ -phosphate (vitamin B6) in whole blood by high-performance liquid chromatography (HPLC) Int. J. Vitam. Nutr. Res. 51:1981;216-222.
15. Steegers-Theunissen R.P., Boers G.H., Steegers E.A., Trijbels F.J., Thomas C.M., Eskes T.K. Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study. Contraception. 45:1992;129-139.
16. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase [letter]. Nat. Genet. 10:1995;111-113.
17. De Stefano V., Dekou V., Nicaud V., Chasse J.F., London J., Stansbie D., Humphries S.E., Gudnason V. Linkage disequilibrium at the cystathionine β synthase (CBS) locus and the association between genetic variation at the CBS locus and plasma levels of homocysteine. The Ears II Group. European Atherosclerosis Research Study. Ann. Hum. Genet. 62:1998;481-490.
18. Ramsbottom D., Scott J.M., Molloy A., Weir D.G., Kirke P.N., Mills J.L., Gallagher P.M., Whitehead A.S. Are common mutations of cystathionine β-synthase involved in the aetiology of neural tube defects? Clin. Genet. 51:1997;39-42.
19. Richter B., Stegmann K., Roper B., Boddeker I., Ngo E.T., Koch M.C. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J. Hum. Genet. 46:2001;105-109.
20. Lentz S.R., Erger R.A., Dayal S., Maeda N., Malinow M.R., Heistad D.D., Faraci F.M. Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine β-synthase-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H970-H975.